BeyondSpring (NASDAQ:BYSI – Get Free Report) and Ovid Therapeutics (NASDAQ:OVID – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership. Institutional & Insider Ownership 40.3% of BeyondSpring shares […]
BeyondSpring (NASDAQ:BYSI – Get Free Report) and Ovid Therapeutics (NASDAQ:OVID – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, dividends, analyst recommendations and valuation. Risk & Volatility BeyondSpring has a beta of […]
NEW YORK, Jan. 10, 2024 (GLOBE NEWSWIRE) BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical.
Former Eisai Board Member, Former World Bank General Counsel, and Lecturer at Harvard and Yale Law Schools, Brings Five Decades of Experience in Global.
NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical.